"Esophagogastric Junction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
| Descriptor ID |
D004943
|
| MeSH Number(s) |
A03.556.875.500.414 A03.556.875.875.330
|
| Concept/Terms |
Esophagogastric Junction- Esophagogastric Junction
- Junction, Esophagogastric
- Gastroesophageal Junction
- Gastroesophageal Junctions
- Junction, Gastroesophageal
- Junctions, Gastroesophageal
|
Below are MeSH descriptors whose meaning is more general than "Esophagogastric Junction".
Below are MeSH descriptors whose meaning is more specific than "Esophagogastric Junction".
This graph shows the total number of publications written about "Esophagogastric Junction" by people in this website by year, and whether "Esophagogastric Junction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 1 | 3 |
| 2001 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 2 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Esophagogastric Junction" by people in Profiles.
-
A Standardized Approach to Performing and Interpreting Functional Lumen Imaging Probe Panometry for Esophageal Motility Disorders: The Dallas Consensus. Gastroenterology. 2025 06; 168(6):1114-1127.e5.
-
In Obesity, Esophagogastric Junction Fat Impairs Esophageal Barrier Function and Dilates Intercellular Spaces via Hypoxia-Inducible Factor 2a. Gastroenterology. 2025 05; 168(5):914-930.e19.
-
Phase II study of perioperative camrelizumab and XELOX for locally advanced gastric or gastroesophageal junction adenocarcinoma. Cancer Sci. 2025 Mar; 116(3):736-743.
-
Interrater Reliability of Functional Lumen Imaging Probe Panometry and High-Resolution Manometry for the Assessment of Esophageal Motility Disorders. Am J Gastroenterol. 2023 08 01; 118(8):1334-1343.
-
Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study. Ann Surg Oncol. 2023 Jan; 30(1):426-432.
-
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction. Clin Cancer Res. 2022 07 15; 28(14):3021-3031.
-
A novel EndoFLIP marker during hiatal hernia repair is associated with short-term postoperative dysphagia. Surg Endosc. 2022 07; 36(7):4764-4770.
-
The Clinical Relevance of Manometric Esophagogastric Junction Outflow Obstruction Can Be Determined Using Rapid Drink Challenge and Solid Swallows. Am J Gastroenterol. 2021 02 01; 116(2):280-288.
-
Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation. Neurogastroenterol Motil. 2021 05; 33(5):e14055.
-
Per-Oral Endoscopic Myotomy for Esophagogastric Junction Outflow Obstruction: A Multicenter Pilot Study. Clin Gastroenterol Hepatol. 2021 08; 19(8):1717-1719.e1.